These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34348730)

  • 1. Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma.
    Xiong F; Wu GH; Wang B; Chen YJ
    Cancer Cell Int; 2021 Aug; 21(1):411. PubMed ID: 34348730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
    Pan PJ; Liu JX
    World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of Differential Expression Autophagy Genes Related to the Prognosis of Diffuse Large B-Cell Lymphoma and Establishment of an Autophagy Model].
    Zhang JD; Zhang HM; Lu D; Wang ZN; Chen HR; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1101-1108. PubMed ID: 35981368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
    Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.
    Zhang Q; Zhu Z; Guan J; Zheng C
    Front Oncol; 2022; 12():904614. PubMed ID: 35814424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
    Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
    World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling.
    Xin Z; Li D; Mao F; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
    J Cell Physiol; 2020 Nov; 235(11):8416-8423. PubMed ID: 32239705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
    Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
    Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
    Zhang S; Wang H; Liu A
    Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
    Zheng W; Lin Q; Issah MA; Liao Z; Shen J
    BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression.
    Zhao F; Li S; Liu J; Wang J; Yang B
    Hum Cell; 2022 Jul; 35(4):1234-1247. PubMed ID: 35676608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
    Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
    Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
    Qian Z; Chen L; Wang X; Kan Y; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Ge P; Ding T; Zhai Q; Zhao H
    Clin Exp Med; 2022 May; 22(2):183-191. PubMed ID: 34427833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
    Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
    Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
    Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
    Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
    Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.